Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al.
University of Alabama at Birmingham.
Jeffrey R
JR
Curtis
New York University Langone Medical Center, New York, NY.
Grace C
GC
Wright
Stanford University School of Medicine, Stanford, CA.
Vibeke
V
Strand
CSD Biostatistics, Inc., Oro Valley, AZ.
Charles S
CS
Davis
Crescendo Bioscience, South San Francisco, CA.
Elena
E
Hitraya
Crescendo Bioscience, South San Francisco, CA.
Eric H
EH
Sasso
D000069594:Abatacept; D000068879:Adalimumab; D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid; D001688:Biological Products; D015415:Biomarkers; D006801:Humans; D008727:Methotrexate
D018501:Antirheumatic Agents; D001688:Biological Products; D015415:Biomarkers; D000069594:Abatacept; D000068879:Adalimumab; D008727:Methotrexate